Medical management of hyperlipidaemia.
There is increasing evidence that plasma cholesterol, and particularly low-density lipoprotein cholesterol, has a causal role in atherogenesis. The benefits of cholesterol lowering in terms of reduction of coronary heart disease is well established. This should encourage the identification and treatment of patients with hyperlipidaemia.